Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gen-Probe

This article was originally published in The Gray Sheet

Executive Summary

Judgment in favor of Gen-Probe is entered in a patent infringement lawsuit filed in 1993 by the Center for Neurologic Study challenging ownership of patents covering Gen-Probe's technologies for detecting disease-causing organisms using genetic probes targeting ribosomal RNA, the company says. Gen-Probe has a patent infringement suit pending against Amoco Technology, which funded the CNS suit and an earlier suit by the University of California, and its former subsidiary Vysis, which had rights to obtain an exclusive license to the patents in the event that CNS prevailed

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel